SRTA
Strata Critical Medical Inc
NASDAQ · Health Care
$4.74
+0.34 (+7.73%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 277.15M | 185.98M | 266.07M | 267.03M | 210.56M |
| Net Income | -30,435,562 | -18,381,429 | 23.50M | 21.08M | 13.98M |
| EPS | — | — | — | — | — |
| Profit Margin | -11.0% | -10.4% | 8.8% | 7.9% | 6.6% |
| Rev Growth | +49.0% | +49.0% | -0.5% | +24.6% | +15.9% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 0 | 0 | 82.29M | 82.00M | 97.07M |
| Total Equity | — | — | 203.39M | 203.10M | 210.24M |
| D/E Ratio | — | — | 0.40 | 0.40 | 0.46 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | -32,111,073 | -20,470,755 | 34.29M | 31.18M | 28.19M |
| Free Cash Flow | — | — | 21.84M | 22.50M | 18.25M |